Skip to main content

Corporate publications

Our corporate publications give you a more in depth understanding of who we are, what we do and what our focus will be over the coming months and years.

New business plan for 2019-2020

We have delayed our new business plan for the 2020/21 business year due to the COVID-19 pandemic. We will instead publish a six month plan for the remainder of the 2020 business year sometime in October. This will set out the work we will do by the end of the current business year. We intend to publish our new strategy for 2020-2024 at around the same time.

Meanwhile, we are continuing to carry out our regulatory and licensing work as normal, and providing information to the public, patients and clinics.

Business impact target (BIT)

The business impact target (BIT) is a cross-government target for the reduction of regulation on business.

Under the BIT, the Environment Agency assesses the financial impacts on business of qualifying regulatory provisions (QRPs). QRPs are changes to regulatory practices that are described in a written ministerial statement. We assess the impacts of these changes through BIT assessments.

We submit BIT assessments for QRPs to the Regulatory Policy Committee (RPC) for validation.


Our vision is high quality care for everyone affected by fertility treatment. Our strategy, developed in partnership with our stakeholders, sets out how we're going to achieve that vision in three key areas:

  • safe, ethical, effective treatment
  • consistent outcomes and support
  • improving standards through intelligence

Innovation plan

Our innovation plan sets out the actions that we are taking to ensure that:

  • the UK remains a jurisdiction where innovation can continue to flourish
  • clinical practice and ethical research can continue to develop
  • the public continue to be reassured that nothing is done without expert oversight.

Disclosure of salaries and expenses

To reflect the HFEA’s ongoing commitment to transparency we have published our staff salary bands, expenses incurred by our Directors and Authority members, payment targets and our expenditure.

Read our disclosures of salaries and expenses

; ;

Review date: 30 June 2022